Detailed text transcripts for TV channel - FOXNEWS - 20161218:15:37:00
That allow us to invest in r&d but we don't need to engage in price gauging opportunity or take seeshl double digit price increases. so alogrym can deliver strong shareholder return yet not engage in these practices. we're proving that it's possible. that being said i think we need the rest of the industry to do it and given the pro-growth government that we have coming in, if we get this particular issue under control, i think we're going to have a golden era of innovation. the worst thing we can do is have what hillary clinton suggesting a government takeover of the pharmaceutical industry. ...